What is LOPJLB’s current signal on ARCT?

LOPJLB’s latest quantitative signal on Arcturus Therapeutics Holdings Inc. (ARCT) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is ARCT in?

Arcturus Therapeutics Holdings Inc. (ARCT) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Arcturus Therapeutics Holdings Inc. based / listed?

Arcturus Therapeutics Holdings Inc. is based in US, listed on NASDAQ.

Arcturus Therapeutics Holdings Inc. (ARCT)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$13.74+6.76%Close

SELLCRISIS · day 4

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $391M
Beta: 2.48
P/E (TTM): -3.90

Short % float: 20.56%
Days to cover: 5.9
SI change: -1.6%

1W: +5.45%
1M: -1.72%

vs SPY 1W: +4.29%
vs SPY 1M: -4.71%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United States. Its notable development programs…

Employees: 109
Headquarters: US
Founded: 2013
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 28.4M
Float: 92.0%

arcturusrx.com ↗

Key executives

Joseph E. Payne — Founder, President, Chief Executive Officer & Director

Padmanabh Chivukula — Founder, Chief Scientific Officer, Chief Operating Officer & Secretary

Lance Kurata — Chief Legal Officer

SEC filings

EDGAR · CIK 17682240 · ARCT

Analyst consensus

Buy

Bullish1257.1%

Neutral523.8%

Bearish419.0%

L $20.00Avg $30.50H $41.00

Target$30.50+121.98%

Last$13.74

Key stats

Industry peers

Prediction markets

Company news